Gilead Sciences, Inc.
Inhibitors of bruton'S tyrosine kinase

Abstract:

Provided are forms of 6-amino-9-[(3R)-1-(2-butynoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-di- hydro-8H-purin-8-one, compositions thereof, methods for their preparation, and methods for their use.